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AbstrAct
Objectives The aim of this research is to assess causes 
and circumstances of deaths in extremely low gestational 
age neonates (ELGANs) born in Switzerland over a 3-year 
period.
Design Population-based, retrospective cohort study.
Setting All nine level III perinatal centres (neonatal 
intensive care units (NICUs) and affiliated obstetrical 
services) in Switzerland.
Patients ELGANs with a gestational age (GA) <28 weeks 
who died between 1 July 2012 and 30 June 2015.
Results A total of 594 deaths were recorded with 280 
(47%) stillbirths and 314 (53%) deaths after live birth. 
Of the latter, 185 (59%) occurred in the delivery room 
and 129 (41%) following admission to an NICU. Most 
liveborn infants dying in the delivery room had a GA ≤24 
weeks and died following primary non-intervention. In 
contrast, NICU deaths occurred following unrestricted life 
support regardless of GA. End-of-life decision-making 
and redirection of care were based on medical futility and 
anticipated poor quality of life in 69% and 28% of patients, 
respectively. Most infants were extubated before death 
(87%).
Conclusions In Switzerland, most deaths among infants 
born at less than 24 weeks of gestation occurred in the 
delivery room. In contrast, most deaths of ELGANs with 
a GA ≥24 weeks were observed following unrestricted 
provisional intensive care, end-of-life decision-making and 
redirection of care in the NICU regardless of the degree of 
immaturity.
IntroductIon
Ongoing progress in perinatal care has lead 
to unprecedented survival rates for extremely 
low gestational age neonates (ELGANs). 
Survival of infants who were considered to 
be marginally viable 30 years ago has now 
become the rule rather than the exception.1–4 
In parallel, neonatologists have continued to 
push the limit of viability to lower and lower 
gestational ages (GAs). However, this success 
has its price and the burden of intensive care 
imposed on borderline viable infants who 
ultimately do not survive and high rates of 
neurosensory impairments among survivors 
have raised serious ethical questions.5–9 Many 
national paediatric and neonatal societies 
have responded to these concerns with the 
publication of guidelines to support ethical 
decision-making in the care of borderline 
viable infants.10–16
Swiss obstetricians and neonatologists have 
traditionally had a more restrictive attitude 
towards providing proactive care for infants 
born at the limit of viability. Quality of life 
considerations have always had a high priority. 
Consequently, mortality rates of ELGANs in 
Switzerland are higher compared with some, 
but not all, highly developed countries.17
Following the publication of the first Swiss 
recommendations for the care of infants 
born at the limit of viability (22–26 weeks) 
in 2002,10 improved survival rates for infants 
born at 25 completed weeks of gestation were 
demonstrated in some but not all centres.18 19 
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Research
Strengths and limitations of this study
 ► The current study provides a comprehensive 
assessment of end-of-life decision-making in 
extremely low gestational age neonates  (ELGANs) 
born in all level III perinatal centres in Switzerland 
over a 3-year period.
 ► Since all deaths (including delivery room (DR) deaths, 
stillbirths and late terminations of pregnancy) were 
included in this study, differences in end-of-life 
decision-making between DR and NICU deaths 
could be analysed.
 ► Data collection was restricted to level III perinatal 
centres and therefore ELGANs who have died at 
lower level institutions may have been missed.
 ► Even though almost 600 deaths were included in the 
study, the sample size was too small to allow for 
centre comparison.
group.bmj.com on June 16, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
2 Berger TM, et al. BMJ Open 2017;7:e015179. doi:10.1136/bmjopen-2016-015179
Open Access 
The Swiss guidelines were revised in 2011.20 They empha-
sise the fact that apart from stratification by GA, additional 
factors significantly affecting prognosis (ie, estimated 
fetal weight, sex, exposure or non-exposure to antenatal 
corticosteroids, single or multiple births) must be consid-
ered. The grey zone is more narrowly defined (24 0/7–24 
6/7 weeks of gestation) but its borders are not absolute 
allowing for an individualised approach in the perinatal 
care at the limit of viability. The impact of the revised 
guidelines on end-of-life decision-making is unknown.
The aim of the current study was to examine the reasons 
for end-of-life decision-making and circumstances of 
death in ELGANs born in Switzerland over a 3-year period 
following the publication of the revised guidelines.
Methods
Detailed information on all delivery room (DR) and 
neonatal intensive care unit (NICU) deaths before 
discharge among ELGANs with a GA between 22 to 27 
completed weeks born in Switzerland over a 36-month-pe-
riod (1 July 2012 to 30 June 2015) was collected. Both 
stillborn and liveborn infants were included. Data collec-
tion was organised on-site in the level III NICUs at the 
University Hospitals of Basel, Bern, Geneva, Lausanne 
and Zurich, and the level III NICUs at the Cantonal 
Hospitals of Aarau, Chur, Lucerne and St. Gallen. Swit-
zerland has a well-developed system of regionalised care, 
and the vast majority of ELGANs (>90%) are born in one 
of these perinatal centres.
Patients were identified using clinical records, elec-
tronic databases as well as birth log books. Deidentified 
data were entered by trained research assistants on-site 
into REDCap (Research Electronic Data Capture), a 
secure online database. The system featured easy-to-use 
online screen forms and electronic data validation checks 
to minimise data-entering errors. Confidentiality was 
assured by password protection.
For each patient, date and time of birth as well as the 
perinatal centre where the infant was born were regis-
tered. Additional demographic data included GA in 
weeks and days, birth weight, sex and whether the infant 
was a singleton or child from a multiple birth. Pregnancy 
complications such as premature rupture of membranes, 
clinical chorioamnionitis and maternal hypertension 
were recorded. The use of prenatal steroids as well as the 
type of delivery were assessed. Deliveries occurring after 
spontaneous labour or induction of labour for maternal 
reasons or with the objective to increase chances of infant 
survival were distinguished from late terminations of 
pregnancy.
For stillborn infants, apart from basic demographic 
data, it was assessed whether labour occurred spon-
taneously or was induced for late termination of 
pregnancy. For liveborn infants, DR resuscitation 
measures (intubation, use of surfactant, chest compres-
sions, use of epinephrine) were noted. The reason 
for death in the DR was classified as either primary 
non-intervention, limited resuscitation or full resusci-
tation. For infants who received palliative care only, 
the use of sedatives or analgesics was recorded.
For infants admitted to the NICU, information on severe 
neonatal complications (ie, periventricular/intraventric-
ular haemorrhage, cystic periventricular leukomalacia, 
persistent ductus arteriosus requiring medical or surgical 
therapy, air leak, necrotising enterocolitis, focal intes-
tinal perforation, sepsis and renal failure) and age at 
death were noted. Daily data on cardiovascular and 
respiratory system performance as well as the degree of 
cardiorespiratory support were recorded for 3 days prior 
to death. Based on this information, it was determined 
whether the primary cause of death was related to severe 
congenital malformations, refractory cardiovascular or 
respiratory failure, sepsis, gastrointestinal complications 
or severe neurological injury. In doubtful cases, the data 
were reviewed by the principal investigator (TMB) for 
final classification. In addition, it was recorded whether 
death occurred despite ongoing unrestricted intensive 
care or whether death was preceded by withholding or 
withdrawing of life-sustaining therapies. Reasons for any 
redirection of care (ROC) decisions were classified as 
being due to medical futility or concerns regarding the 
anticipated future quality of life. Finally, the use of any 
medication to alleviate pain and suffering after ROC was 
noted.
statistical analyses
Continuous variables are presented as median and 
IQR, dichotomous variables are presented as absolute 
numbers and percentages. Mann-Whitney U test was used 
to compare medians and χ2 test was used to compare 
proportions. Kruksal-Wallis analysis of variance was used 
to compare >2 medians. A p value of <0.05 was considered 
significant. Kaplan-Meier curves were drawn to compare 
survival time in days by reason for redirection of care. 
Statistical analyses were performed using Stata V.13.
results
All deaths
Overall, 594 deaths of ELGANs were recorded over the 
3-year study period. Of these, 280 (47%) infants were 
stillborn (median GA and birth weight 23 5/7 weeks and 
537 g, respectively) and 314 (53%) died after live birth. 
Of the latter, 185 (59%) died in the DR, and 129 (41%) 
died in the NICU following provisional intensive care 
(figure 1). Median GA and birth weight were higher in 
the infants who died in the NICU (25 2/7 weeks and 690 
g) than in infants who were born alive but died in the DR 
(23 3/7 weeks and 560 g, p<0.01 for both GA and birth 
weight). Infants who died in the NICU had a higher rate 
of exposure to prenatal steroids (p<0.01) and were more 
commonly born by Caesarean section (p<0.01) (88% 
and 64%, respectively) compared with liveborn infants 
who died in the DR (10% and 11%, respectively; data not 
collected for stillborn infants) (table 1).
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Figure 1 Overview of the study population (n=594). DR, delivery room; LTOP, late termination of pregnancy; NICU, neonatal 
intensive care unit.
Table 1 Patient characteristics and comparison of perinatal interventions between DR and NICU deaths after live birth
Liveborn infants n=314
DR deaths NICU deaths p Value
Patient characteristics n=185 n=129
  GA in weeks and days, median (IQR) 23 3/7 (22 5/7–24 1/7) 25 2/7 (24 3/7–26 3/7) <0.01
  Birth weight in grams, median (IQR) 560 (478–643) 690 (580–850) <0.01
  Female, n (%) 76 (41) 61 (47) 0.275
  Multiplets, n (%) 45 (24) 39 (30) 0.245
Obstetrical interventions n=185 n=129
  Any prenatal steroids, n (%) 19 (10) 114 (88) <0.01
  Caesarean delivery, n (%) 21 (11) 82 (64) <0.01
DR interventions n=109* n=129
  Primary non-intervention 102 (93) NA
  Limited resuscitation 4 (4) NA
  Full resuscitation 3 (3) NA
  Intubated in DR 1 (1) 110 (85) <0.01
  Surfactant in DR 0 (0) 101 (78) <0.01
  Epinephrine in DR 1 (1) 5 (4) <0.01
*Liveborn infants after late termination of pregnancy (n=76) are not included.
DR, delivery room; GA, gestational age; NA, not applicable; NICU, neonatal intensive care unit.
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deaths after live birth following spontaneous labour 
or induction of labour for maternal reasons or with the 
objective to increase chances of infant survival
Obstetrical and DR interventions were used only rarely 
in liveborn ELGANs after spontaneous labour at 22 and 
23 weeks, and almost all deaths occurred in the DR (22 
weeks: 100%, 23 weeks: 89%). A more active approach 
was seen at 24 weeks and the proportion of DR deaths 
decreased to 35%. At more than 24 weeks, the majority 
of deaths (≥95%) were observed in the NICU (table 2).
circumstances of dr deaths
Overall, 465 (78%) of all deaths were recorded in the DR. 
Of these, 270 were born after spontaneous labour (161 
(60%) stillborn and 109 (40%) live born) (figure 1). 
Regardless of GA, active perinatal interventions were used 
only in a minority of liveborn infants after spontaneous 
labour who later died in the DR. Failed resuscitation 
attempts were rare (n=7) (table 1). The remaining DR 
deaths (n=195) occurred in the context of late termina-
tion of pregnancy. Of these, 119 (61%) were stillborn 
and 76 (39%) were born alive and died following primary 
non-intervention (figure 1). In all DR deaths, the use of 
drugs for palliative care was either rare or, alternatively, 
poorly documented.
circumstances of nIcu deaths
A total of 129 ELGANs died following NICU admission 
(22% of all deaths recorded). To analyse whether the 
degree of immaturity had an impact on the circum-
stances of death in the NICU, two groups of ELGANs 
were compared: infants with a GA <25 weeks (group 1) 
and infants with a GA ≥25 weeks (group 2).
For both groups, medical futility was the predominant 
reason given for end-of-life decision-making in the NICU 
(mentioned in 65% and 72% of group 1 and group 2 
patients, respectively); quality-of-life considerations was 
the reason for ROC decisions in 33% and 26% of these 
patients (table 3).
Independent of their GA, most infants were on invasive 
respiratory support in the 3 days preceding death (>90%); 
however, at the time of death, the majority (≥85%) was 
extubated. The use of advanced life-sustaining therapies 
was comparable between the two groups. Cardiopulmo-
nary resuscitation (CPR) within 12 hours of death was 
noted in 14 of the 129 patients who died in the NICU (7% 
and 13% in group 1 and group 2 infants, respectively). 
The use of morphine after ROC was common (>50%); 
benzodiazepines, on the other hand, were administered 
in ≤15% of dying infants (table 3).
Among all infants admitted to NICU who ultimately did 
not survive, 50% had died by day of life 6, and 75% by day 
of life 17. The age at death of ELGANs dying following 
ROC because of medical futility was comparable to that 
of ELGANs in whom life-sustaining therapies were with-
drawn because of quality-of-life considerations (figure 2). 
Early deaths were observed in infants with severe neuro-
logical injury and refractory cardiovascular failure with 
50% having died on day of life 1 and 2, respectively. In 
contrast, 50% of ELGANs with severe congenital malfor-
mations, sepsis and refractory respiratory failure survived 
for more than 1 week. Finally, gastrointestinal compli-
cations were associated with the latest deaths with 50% 
having died by day of life 19 (table 4).
dIscussIon
The results of the current study provide a comprehensive 
assessment of all deaths among infants born between 22 
and 27 completed weeks of gestation in Switzerland over a 
3-year period. Previous reports have been limited to Swiss 
single-centre experiences of neonatal deaths (preterm 
and term infants), and have excluded stillbirths21–23 or 
even all DR deaths,23 as well as deaths of infants with a GA 
below 2322 or 24 weeks.21
Antenatal and intrapartum stillbirths accounted for a 
large proportion (47%) of all deaths among ELGANs. 
While some stillbirths cannot be prevented, others, 
particularly in the most immature ELGANs, will occur 
in the context of non-active obstetrical management.24 
Stillbirths are inconsistently reported and thus constitute 
a significant hidden mortality. The time point at which 
researchers begin to observe outcomes (ie, their incep-
tion point) significantly influence outcome statistics for 
extremely preterm births.25
For infants dying following live birth after spontaneous 
labour, GA appeared to be the major factor when deci-
sions about initiation of life-sustaining measures in the DR 
were made, leading to three distinct categories. First, at 
22–23 weeks, proactive perinatal interventions were rarely 
used and preference was given to palliative care. Obvi-
ously, death was the planned and accepted outcome, and, 
consequently, the majority of deaths occurred in the DR 
(100% and 89% at 22 and 23 weeks, respectively). Second, 
at 24 weeks, a proactive approach became more common 
and deaths were distributed more evenly between the 
DR (35%) or the NICU (65%). Third, at GAs ≥25 weeks, 
active care was the rule and the large majority of deaths 
(≥95%) occurred in the NICU following a period of unre-
stricted intensive care. Our findings closely mirror the the 
results of the Etude Epidémiologique sur les Petits Ages 
Gestationnels (EPIPGAGE-2) study from France, which 
also demonstrated that decision-making in the DR was 
based almost exclusively on GA.26 In an accompanying 
editorial, Janvier and Lantos warned of the harms of the 
GA label and the fact that (restrictive) policies not only 
reflected outcomes but, in fact, would shape them.27
Given the high concordance between obstetrical and 
neonatal non-interventions, it appears that these deci-
sions had been made prior to delivery and were rarely—if 
ever —revised after birth. These observations suggest 
that Swiss obstetricians and neonatologists consider a 
narrow window (ie, 24 weeks of gestation) as what has 
been described as the ‘grey zone’ of infant viability.28 29 
This is largely consistent with the current Swiss guidelines 
on perinatal care at the limit of viability, which favour 
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palliative care for infants born at 22–23 weeks of gesta-
tion and active obstetrical and neonatal interventions 
at 25 weeks of gestation. At 24 weeks, an individualised 
approach based on additional prognostic factors is recom-
mended.20
Our data indicate that once infants had been admitted 
to an NICU, intensive care was provided without a priori 
restriction. In contrast to decision-making in the DR, GA 
was no longer an important factor when caregivers and 
parents had to decide between ongoing intensive care or 
ROC in the NICU. The intensity of life-sustaining thera-
pies used also suggests that limitation (ie, withholding) 
of intensive care measures was uncommon. However, 
when such therapies appeared to fail (mentioned in 
65% of patients) or, less commonly, concerns regarding 
the future quality of life became important (mentioned 
in 29% of patients), life-sustaining therapies, were with-
drawn in most patients.
Previous single-centre reports from Switzerland 
analysing deaths of both preterm and term infants 
have documented high rates of primary non-interven-
tion among infants dying in the DR21 22 and high rates 
of end-of-life decision-making for infants dying in the 
NICU.21–23 Deaths despite maximum intensive care were 
Table 3 Patient characteristics, reasons for end-of-life decisions and circumstances of death among infants admitted to the 
NICU (n=129)
Patient characteristics <25 weeks (n=45) ≥25 weeks (n=84) p Value
  GA in weeks and days, median (IQR) 24 3/7 (24 1/7–24 4/7) 26 0/7 (25 2/7–26 6/7) <0.0001
  Birth weight in grams, median (IQR) 630 (590–710) 735 (500–735) <0.0001
  Female, n (%) 22 (49) 39 (46) 0.79
  Multiplets, n (%) 17 (38) 22 (26) 0.172
Reason for end-of-life decision
  Medical futility, n (%) 29 (65) 60 (72)
  Poor quality of life anticipated, n (%) 15 (33) 22 (26)
  Missing, n (%) 1 (2) 2 (2) 0.69
Respiratory support within 3 days of death
  No mechanical ventilation, n (%) 0 (0) 0 (0)
  CPAP only, n (%) 0 (0) 2 (2)
  CMV, n (%) 18 (40) 44 (52)
  HFOV, n (%) 23 (51) 34 (40)
  Unknown, n (%) 4 (9) 4 (5) 0.31
  Inhaled nitric oxide, n (%) 9 (20) 13 (15) 0.42
  Maximum FiO2, mean (SD) 0.77 (0.24) 0.8 (0.29) 0.75
Cardiovascular support within 3 days of death
  Dopamine, n (%) 14 (31) 38 (45) 0.11
  Maximum dopamine dose in µg/kg/min, mean (SD) 10 (6) 14 (6) 0.049
  Epinephrine, n (%) 9 (20) 16 (19) 0.9
  Maximum epinephrine dose in µg/kg/min, mean (SD) 0.5 (0.5) 0.4 (0.3) 0.5
  CPR within 12 hours of death, n (%) 3 (7) 11 (13) 0.088
Circumstances after ROC
  Intubated at time of death, n (%) 4 (9) 13 (15) 0.095
  Morphine administration after ROC, n (%) 18 (40) 56 (67) 0.003
  Benzodiazepine administration after ROC, n (%) 5 (11) 13 (15) 0.128
χ2 for proportions, Mann-Whitney U test for continuous variables.
Values in bold typeface are statistically significant at p<0.05.
CMV, conventional mechanical ventilation; CPAP, continuous positive airway pressure; CPR, cardiopulmonary resuscitation; FiO2, fractional inspired oxygen; GA, 
gestational age; HFOV, high-frequency oscillatory ventilation; NICU, neonatal intensive care unit; ROC, redirection of care.
Figure 2 Kaplan-Meier survival curves for infants admitted 
to the NICU (n=129): redirection of care (ROC) because of 
medical futility (n=89) versus ROC because of anticipated 
poor quality of life (n=36) (information on reason for ROC 
missing for three patients). NICU, neonatal intensive care unit.
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much less common and were described for 3%–11% of 
all DR deaths and 8%–21% of all NICU deaths. In an 
international study from four perinatal centres in three 
different countries (USA: Chicago, Milwaukee; Canada: 
Montreal and the Netherlands: Groningen), Verhagen 
et al observed striking differences in neonatal end-of-
life decision-making and circumstances of death.30 In 
Chicago, there were no DR deaths, no ROC for quality of 
life reasons, and 31% of NICU deaths occurred following 
CPR attempts. In contrast, in the three other centres, DR 
deaths were described in 16%–22%, elective extubation 
for quality-of-life reasons occurred in 19%–35% of NICU 
deaths and CPR was uncommon (4%–12%). Obviously, 
neonatal end-of-life decisions are not only evidence based 
but vary widely between countries31 and can be signifi-
cantly affected by an individual NICU’s culture.30 32 33
In our study, the age at death was influenced by the 
principal failing organ system but not by the reason for 
ROC. This observation is consistent with the results from 
a recently published large study from the USA, which 
also found timing of death was cause-specific.34 With 
increasing awareness that end-of-life decision-making is 
associated with significant uncertainty,29 35 several reports 
have documented that deaths of patients in the NICU in 
recent years occurred later than in the past.33 36
ELGANs who died in the DR after live birth (both after 
late termination of pregnancy and following spontaneous 
labour or induction of labour for maternal reasons or with 
the objective to increase chances of infant survival) rarely 
received drugs to relieve pain and suffering, whereas 
more than 50% of patients who died in the NICU received 
opiates and/or benzodiazepines. Available evidence from 
the literature suggests that this is a common phenom-
enon not restricted to preterm infants.36–38 More recently, 
however, Durrmeyer et al found much higher rates of 
pharmacological palliation among 73 DR deaths from the 
more recent EPIPAGE-2 cohort, with 35 infants receiving 
some form of comfort medication, primarily in an attempt 
to diminish gasping.39
Our study has several limitations: data collection was 
restricted to the Swiss level III perinatal centres and we 
may have missed some ELGANs who have died at lower 
level institutions. However, this number is likely to be 
small because antenatal referral of high-risk pregnancies 
is well established in Switzerland. Even though almost 600 
deaths were included in the study, the sample size is too 
small to allow for centre comparison. Medical records are 
hospital specific and non-uniform; data quality is, there-
fore, likely to vary.
conclusions
In Switzerland, most deaths among infants born at less 
than 24 weeks of gestation occurred in the DR. The 
decision for primary non-intervention appeared to 
be primarily based on GA. In contrast, most deaths of 
ELGANs with a GA ≥24 weeks were observed following 
unrestricted provisional intensive care, end-of-life deci-
sion-making and ROC in the NICU regardless of the 
degree of immaturity.
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Table 4 Principal cause of death and survival time in days of infants admitted to the NICU (n=129)
Principal cause of death Days
n 25% died 50% died 75% died
Severe congenital malformations 27 2 6 11
Sepsis 24 3 6 12
Cardiovascular failure 21 1 2 17
Respiratory failure 21 3 8 16
Gastrointestinal complication 19 6 19 28
Neurological complication 8 1 1 7
In nine cases, principal cause of death could not be determined.
NICU, neonatal intensive care unit.
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